The global medical animation market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, growing at a CAGR of 20.8% from 2016 to 2021.
The global medical animation market is segmented on the basis of type, application, therapeutic area, and end user. By type, the market is categorized into 3D animation, 2D animation, 4D animation, and flash animation. The 3D Animation segment is expected to account for the largest share of the market in 2016. The largest share of this segment is mainly attributed to the fact that 3D animation provides viewers a greater sense of perspective, and enables clear understanding of the key concepts in the forensic case. However, the 4D animation segment is expected to grow at the highest CAGR during the forecast period.

The medical animation market, based on application, is segmented into drug MoA and approval, patient education, surgical training & planning, cellular and molecular studies, and other applications (medical simulation, forensic reconstruction, and emergency care instruction). The drug MoA and approval segment is expected to account for the largest share of the market in 2016. This is mainly attributed to the rising adoption of medical animation by pharmaceutical companies for showcasing the MoA of drugs as well as for the marketing, promotions, and approvals of drugs. However, the patient education segment is expected to grow at the highest CAGR during the forecast period.

On basis of therapeutic area, the market is segmented into oncology, cardiology, cosmeceuticals/ plastic surgery, dental, and other therapeutic areas (ENT, digestive system, orthopedic, ophthalmology, neurology, and gynecology). The other therapeutic areas segment is expected to account for the largest share of the market in 2016. This is attributed to the increasing awareness amongst healthcare professionals on various diseases, injuries, and defects; and rising adoption among academic institutes to explain and provide instructions to students on physiotherapy and pre- and post-orthopedic procedures. However, the cosmeceuticals/ plastic surgery segment is expected to grow at the highest CAGR during the forecast period.

On the basis of end users, the medical animation market is segmented into life science companies; hospitals, surgical centers, and clinics; academic institutes; medical equipment manufacturers; and other end users (medico-legal firms, forensic departments, government bodies, and insurance companies). The life sciences companies segment is expected to account for the largest share of the market in 2016, and is projected to grow at the highest CAGR during the forecast period. Life sciences companies mainly use medical animation as a marketing tool to promote new drugs and product offerings, thus attributing to the growth of this market.

On the basis of regions, the medical animation market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. The large share of the North American region can be attributed to the presence of major pharmaceutical companies, increased healthcare spending, presence of top market players, increasing number of surgeries in the U.S., and growing medical devices industry in Canada. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

※関連の医療情報レポート

高薬理活性原薬（HPAPI）の世界市場予測（～2023年）：種類、合成、メーカー、治療分野MAM-PH-4897 / MarketsandMarkets / 2018年4月18日 / MarketsandMarketsが発行した当調査レポートでは、高薬理活性原薬（HPAPI）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、合成別分析、メーカー別分析、治療分野別分析、高薬理活性原薬（HPAPI）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 17.72 Billion in 2018, at a CAGR 8.7%. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. This report segments the HPAPIs market into type, type of manufacturer, type of synthesis, therapeutic application, and region. Based on type, the HPAPI market is segmented into innovative and generic APIs. In 2018, the innovative HPAPIs segment...

抗体産生の世界市場：産生プロセス、エンドユーザー、市場予測MAM-BT-3363 / MarketsandMarkets / 2016年8月18日 / 当調査レポートでは、抗体産生の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、プロセス別分析、需要先別分析、地域別分析、抗体産生の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The antibody production market is projected reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, growing at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market is segmented on the basis of process and end users. By process, the market is segmented into upstream processing, downstream processing, and filtration. The downstream processing segment is expected to account for the largest share of the market in 2016, and is projected to grow at the highest CAGR during the forecast period. This large share can be attributed to the requirement of sensitive...

ウイルス不活化の世界市場：製品（キット、試薬、装置、サービス）、用途、方法、エンドユーザー、地域別分析BT-4361 / MarketsandMarkets / 2016年6月6日 / 当調査レポートでは、ウイルス不活化の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、方式別分析、需要先別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global viral inactivation market is valued at USD 320.5 Million in 2016 and is expected to grow at a CAGR of 12.3%, to reach USD 573.0 Million by 2021. Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise. Also, many of pharmaceutical and biotechnology firms are gearing...

感染症サーベイランスソリューションの世界市場：ソフトウェア、サービス、エンドユーザー、地域別分析HIT-4380 / MarketsandMarkets / 2016年6月14日 / 当調査レポートでは、感染症サーベイランスソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、製品別分析、サービス別分析、需要先別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global infection surveillance solutions market is estimated to reach USD 508.8 Million by 2021, at a CAGR of 14.1% during the forecast period. The market is primarily driven by the increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditures, and increasing number of surgeries. On the other hand, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are some factors that are expected to limit the growth of the market in the coming years. The global infection...

超音波の世界市場予測（～2021年）：技術（診断、治療、2D、3D/4D、HIFU）、ディスプレイ、携帯性、用途、エンドユーザーMAM--MD-2885 / MarketsandMarkets / 2017年3月2日 / 当調査レポートでは、超音波の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、ディスプレイ別分析、携帯性別分析、用途別分析、超音波の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global ultrasound market is expected to reach USD 6.86 Billion by 2021 at a CAGR of 5.2% during 2016 to 2021. A number of factors such as rising patient population base for chronic and lifestyle-related disorders, technological advancements, and growing market demand for minimally invasive diagnostic and therapeutic techniques are driving the growth of the market. Based on technology, the market is segmented into diagnostics and therapeutics ultrasound. Diagnostic ultrasound accounted for the largest share of the market in 2016 owing to factors such as the large-scale use of 2D ultrasound in disease diagnosis, the availability of significant medical...

試料調製の世界市場：装置（ワークステーション、液体取扱システム）、消耗品（キット、フィルター）、用途、エンドユーザー、地域別分析AST-4381 / MarketsandMarkets / 2016年6月14日 / 当調査レポートでは、試料調製の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The sample preparation market is expected to reach USD 7,203.2 Million by 2021 from USD 5,512.2 Million in 2016, growing at a CAGR of 5.5% from 2016 to 2021. The sample preparation market is segmented on the basis of product, application, and end user. By product, the market is categorized into instruments, consumables, and accessories. Consumables segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR during the forecast period. The largest share of this segment is attributed to frequent requirement of replacing the consumables leading to...

感染予防の世界市場予測（～2022年）：消毒製品、殺菌製品、エンドユーザー、地域別分析MAM-MD-3503 / MarketsandMarkets / 2017年12月19日 / MarketsandMarketsが発行した当調査レポートでは、感染予防の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、消毒製品別分析、殺菌製品別分析、需要先別分析、地域別分析、感染予防の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global infection market is projected to reach USD 21.06 Billion by 2022 from USD 15.35 Billion in 2017, at a CAGR of 6.5% during the forecast period. The growth of the market can be attributed to the increasing demand of disinfection and sterilization products and services among pharmaceutical companies, hospitals, and medical device manufacturers; increasing prevalence of hospital-acquired infections; growth in the number of surgical procedures; and rising focus on food sterilization and disinfection. Also, factors such as the growth in the medical devices market, emerging markets, and the rising importance of single-use medical nonwovens and medical devices are...

単細胞解析の世界市場：製品（ビーズ、マイクロプレート、試薬、フローサイトメーター、顕微鏡、分光光度計）、細胞種類、技術（NGS、PCR）、用途、エンドユーザー、地域別分析MAM-BT-4224 / MarketsandMarkets / 2016年4月13日 / 当調査レポートでは、単細胞解析の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品種類別分析、細胞種類別分析、技術別分析、用途別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global single-cell analysis market consists of various products which are used to analyze single-cell, after the isolation from tissues in a multicellular organism. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growth potential of Single-cell sequencing. High potential growth in emerging markets have opened an array of opportunities for the market. However, high cost of single-cell analysis instruments is hampering the growth of the global market. The single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion...

解凍装置の世界市場予測（～2022年）：種類、サンプル（血、血漿、RBC、血小板、全血、胎芽、精液）、エンドユーザーMD-5756 / MarketsandMarkets / 2017年11月23日 / MarketsandMarketsが発行した当調査レポートでは、解凍装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、サンプル別分析、需要先別分析、地域別分析、解凍装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. The market growth is primarily driven by the growing incidence of chronic diseases and technological advancements in thawing devices. The global thawing system market is segmented by type, sample type, end user, and region. By type, the thawing system market is segmented into manual and automated devices. The manual devices segment is estimated to account for the largest market share of the global thawing system market in 2017. Factors driving the growth of this segment...

ゲノム編集/ゲノム工学の世界市場予測（～2022年）：技術（CRISPR、TALEN、ZFN）、用途、エンドユーザーBT-3380 / MarketsandMarkets / 2017年11月20日 / MarketsandMarketsが発行した当調査レポートでは、ゲノム編集/ゲノム工学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、用途別分析、需要先別分析、地域別分析、ゲノム編集/ゲノム工学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global genome editing/genome engineering market is projected to reach USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5%. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. By technology, the genome editing/genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to account...